High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; 19 of the 49 sources its claims cite were checked for support.
Abstract
It has been hypothesized that insulin resistance is mediated by a deficiency of mitochondria in skeletal muscle. In keeping with this hypothesis, high-fat diets that cause insulin resistance have been reported to result in a decrease in muscle mitochondria. In contrast, we found that feeding rats high-fat diets that cause muscle insulin resistance results in a concomitant gradual increase in muscle mitochondria. This adaptation appears to be mediated by activation of peroxisome proliferator-activated receptor (PPAR)δ by fatty acids, which results in a gradual, posttranscriptionally regulated increase in PPAR γ coactivator 1α (PGC-1α) protein expression. Similarly, overexpression of PPARδ results in a large increase in PGC-1α protein in the absence of any increase in PGC-1α mRNA. We interpret our findings as evidence that raising free fatty acids results in an increase in mitochondria by activating PPARδ, which mediates a posttranscriptional increase in PGC-1α. Our findings argue against the concept that insulin resistance is mediated by a deficiency of muscle mitochondria.
Overview
CoChat Summary
TL;DR
High-fat diets in rats caused muscle insulin resistance while simultaneously increasing muscle mitochondria and fat oxidative capacity, arguing against the idea that insulin resistance is mediated by mitochondrial deficiency. The increase in mitochondria appeared mediated by PPARδ activation and a posttranscriptional increase in PGC-1α protein.
Key findings
- High-fat diets raised serum free fatty acids (756 ± 68 μM vs. 249 ± 24 μM, P < 0.01) and increased intraabdominal fat (12.2 ± 1.1 g vs. 7.7 ± 0.5 g, P < 0.01).
- Despite muscle insulin resistance—e.g., insulin-stimulated 2-deoxyglucose transport in soleus was 3.4 ± 0.3 vs. 5.9 ± 0.6 μmol·ml−1·30 min−1, P < 0.05—muscle mitochondria increased: palmitate oxidation rose from 10.2 ± 1.8 to 17.8 ± 2.5 nmol/min per g (P < 0.02), mitochondrial DNA copy number increased, and mitochondrial proteins increased.
- PGC-1α protein increased 2.5-fold after 4 wk of high-fat diet without an increase in PGC-1α mRNA; PPARδ overexpression in tibialis anterior increased PPARδ protein ≈2-fold and PGC-1α protein ≈4-fold, also without an increase in PGC-1α mRNA.
- The mitochondrial response was slow: no increases in mitochondrial proteins at 1 wk, small increases at 2 wk, and significant increases by 4 wk; LCAD and UCP3 increased 50–60% by 2 wk.
Methods
- Male Wistar rats weighing ≈50 g were fed standard chow or high-fat flaxseed/olive oil or lard/corn oil diets for 1–5 wk; body weights, intraabdominal fat depots, and serum free fatty acids were measured.
- Muscle glucose transport was measured with 2-deoxy-d-[3H]glucose in soleus and epitrochlearis; palmitate oxidation was measured by [14C]CO2 production; mitochondrial proteins, PGC-1α protein, mRNA, and mitochondrial DNA content were assessed by Western blotting, semiquantitative RT-PCR, and PCR.
- PPARδ was overexpressed in tibialis anterior by electric pulse-mediated gene transfer; immunoprecipitation and Western blotting were used; comparisons used unpaired Student t tests, with results as means ± SE.
Limitations
- Stated limitations: Not stated in the paper.
- Evident limitations: the study is in rats, not humans; insulin resistance was assessed in isolated muscles; the PPARδ-to-PGC-1α posttranscriptional mechanism is inferred from overexpression and prior binding data rather than directly proven; mitochondrial function was assessed mainly through marker proteins, DNA copy number, and palmitate oxidation capacity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 2 Not valid · 8 Not checked · 32 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have previously reported that raising FFA by means of a high-fat diet plus daily heparin injections for 4 wk does not result in an increase in PGC-1α mRNA in muscle (16).”
What the sources say
- Supportedcites [16] Garcia-Roves PM, et al. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA. 2007;104:10709–10713. doi: 10.1073/pnas.0704024104. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Results report that raising plasma FFA had no effect on PGC-1α levels in skeletal muscle (Fig. 3) and describe daily FFA elevation for four weeks in rats fed a high-fat diet and given heparin. The Materials and Methods specify RT-PCR measurement of PGC-1α gene expression in muscle, supporting the claim’s reference to mRNA. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have shown that raising serum FFA, which are endogenous ligands of PPARδ (20), results in activation of PPARδ, as evidenced by a large increase in PPARδ binding to the PPAR response element in the carnitine palmitoyl transferase 1 (CPT-1) promoter (16).”
What the sources say
- Supportedcites [16] Garcia-Roves PM, et al. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA. 2007;104:10709–10713. doi: 10.1073/pnas.0704024104. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Results report a large increase in PPARδ binding to the PPAR response element on the mCPT-1 promoter in skeletal muscle of rats with raised plasma FFA, and interpret it as evidence of PPARδ activation. The Discussion reiterates that interpretation. The claim concerns activation, not an increase in PPARδ expression. (LLM, conf=0.94)
- Supportedcites [20] Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA. 1997;94:4312–4317. doi: 10.1073/pnas.94.9.4312. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Citation (20) is attached to the statement that free fatty acids are endogenous PPARδ ligands, not to the subsequent in-vivo activation and CPT-1 promoter findings, which the sentence cites to (16). The Results section reports that the naturally occurring fatty acids linoleic and arachidonic acid activated PPARδ and acted as ligands in its binding assay. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The finding that overexpression of PPARδ in skeletal muscle of transgenic mice does not result in an increase in PGC-1α mRNA led to the conclusion that the increase in mitochondria is mediated directly by PPARδ (17–19).”
What the sources say
- Not checked — no full text of the sourcecites [17] Luquet S, et al. Peroxisome proliferator-activated receptor δ controls muscle development and oxydative capability. FASEB J. 2003;17:2299–2301. doi: 10.1096/fj.03-0269fje. [DOI] [PubMed] [Google Scholar] source
- Supportedcites [18] Wang Y-X, et al. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol. 2004;2:1532–1539. doi: 10.1371/journal.pbio.0020294. [DOI] [PMC free article] [PubMed] [Google Scholar] source
In Results, under “Activation of PPARδ Leads to Muscle Fiber Transformation” (page unavailable), the paper reports that PGC-1α levels remained unchanged in the transgenic mice while discussing its muscle mRNA analysis. It describes the mitochondrial changes as apparent direct consequences of PPARδ activation. The transgene was activated VP16-PPARδ, rather than simple overexpression of wild-type PPARδ. (LLM, conf=0.91)
- Could not verifycites [19] Barish GD, Narkar VA, Evans RM. PPARδ: A dagger in the heart of the metabolic syndrome. J Clin Invest. 2006;116:590–597. doi: 10.1172/JCI27955. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The “PPAR δ action in skeletal muscle” section (p. 3) reports effects of muscle-specific PPARδ overexpression on oxidative genes and enzyme activity, but does not report whether PGC-1α mRNA increased. Searches for PGC-1α and the proposed direct mitochondrial mechanism found no passage addressing that point. (LLM, conf=0.73)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have found that raising serum FFA in rats by feeding them a high-fat diet and giving them daily heparin injections results in an increase in muscle mitochondria (16).”
What the sources say
- Supportedcites [16] Garcia-Roves PM, et al. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA. 2007;104:10709–10713. doi: 10.1073/pnas.0704024104. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Abstract states that rats fed a high-fat diet and given daily heparin injections had raised plasma FFA and increased mitochondrial biogenesis in muscle. The Results also report increased mitochondrial enzyme levels and mitochondrial DNA copy number in these rats. The supplied passages do not specify page numbers. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Both overexpression and activation of PPARδ result in increased mitochondrial biogenesis in the absence of an increase in PGC-1α mRNA in skeletal muscle in vivo (17–19).”
What the sources say
- Not checked — no full text of the sourcecites [17] Luquet S, et al. Peroxisome proliferator-activated receptor δ controls muscle development and oxydative capability. FASEB J. 2003;17:2299–2301. doi: 10.1096/fj.03-0269fje. [DOI] [PubMed] [Google Scholar] source
- Partly supportedcites [18] Wang Y-X, et al. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol. 2004;2:1532–1539. doi: 10.1371/journal.pbio.0020294. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results section (page unavailable) reports increased mitochondrial DNA in mice expressing activated VP16-PPARδ while PGC-1α levels remained unchanged. It also reports upregulation of mitochondrial-biogenesis genes after agonist treatment, but does not establish unchanged PGC-1α mRNA for that treatment. The Discussion distinguishes activation from simple overexpression of wild-type PPARδ, so the claim is broader than this paper supports. (LLM, conf=0.88)
- Partly supportedcites [19] Barish GD, Narkar VA, Evans RM. PPARδ: A dagger in the heart of the metabolic syndrome. J Clin Invest. 2006;116:590–597. doi: 10.1172/JCI27955. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The “PPAR δ action in skeletal muscle” section (p. 3) reports that constitutively active PPARδ increases oxidative fibers and mitochondrial-respiration gene expression in rodents, while wild-type overexpression enhances oxidative enzyme activity. It does not establish increased mitochondrial biogenesis for both overexpression and activation, or say that these effects occur without an increase in PGC-1α mRNA. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
28 more claims · 2 with their cited sources checked
Create a free account to see all 53 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This latter function may be critically important in the settings of obesity and diabetes, because these disorders impose a heavy lipid load on muscle mitochondria (5,46,47).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar observations emerged from other laboratories that likewise reported increased oxidative capacity, β-oxidation enzyme activities and mitochondrial biogenesis in parallel with high fat feeding and the onset of both obesity and insulin resistance in rodents [26,30,51,85,96].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the fact that mice on a high-fat diet develop insulin resistance despite an increased mitochondrial content (32)”
From Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes (2012) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, mitochondrial dysfunction is observed only after prolonged high-fat feeding, while insulin resistance develops earlier (Hancock et al, 2008).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Hancock et al, 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Instead, the high-fat diet induced a gradual increase in skeletal muscle mitochondria as indicated by an increase in mitochondrial DNA (mtDNA) and proteins with a mechanism dependent on peroxisome proliferator-activated receptor δ (PPARδ) activation and upregulation of PGC 1α (Hancock et al., 2008).”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Hancock et al., 2008
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Current protocols in molecular biology
(1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90131-4 · Cited by 4,160
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 1×
“The coordinated activation of these transcription factors and, thus, the regulation of mitochondrial biogenesis, is mediated by the transcription coactivator PGC-1 (22, 24).”
BackgroundForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Adaptations of skeletal muscle to endurance exercise and their metabolic consequences
Holloszy, J. O., & Coyle, E. F. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.56.4.831 · Cited by 1,985
Self-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Cited by
Items 101–133 of 133
Skeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes.
Bajpeyi, S., Pasarica, M., Moro, C., Conley, K., Jubrias, S., Sereda, O., Burk, D. H., Zhang, Z., Gupta, A., Kjems, L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1621 · Cited by 84
Regulation of skeletal muscle mitochondrial function: genes to proteins
Lanza, I. R., & Sreekumaran Nair, K. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02124.x · Cited by 83
Houzelle, A., Jörgensen, J. A., Schaart, G., Daemen, S., van Polanen, N., Fealy, C. E., Hesselink, M. K. C., Schrauwen, P., & Hoeks, J. (2021) · Diabetologia · doi:10.1007/s00125-020-05335-w · Cited by 83
Mitochondrial Respiratory Capacity and Content Are Normal in Young Insulin-Resistant Obese Humans
Fisher-Wellman, K. H., Weber, T. M., Cathey, B. L., Brophy, P. M., Gilliam, L. A. A., Kane, C. L., Maples, J. M., Gavin, T. P., Houmard, J. A., & Neufer, P. D. (2014) · Diabetes · doi:10.2337/db13-0940 · Cited by 82
Laye, M. J., Rector, R. S., Borengasser, S. J., Naples, S. P., Uptergrove, G. M., Ibdah, J. A., Booth, F. W., & Thyfault, J. P. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91186.2008 · Cited by 77
“Though findings are not universal (12;25), extremely obese and type 2 diabetic subjects display reduced systemic and skeletal muscle FAO, which has been linked to increased adiposity, increased intramuscular lipid storage, and skeletal muscle insulin resistance (5;14;21;44).”
BackgroundKacerovsky-Bielesz, G., Chmelik, M., Ling, C., Pokan, R., Szendroedi, J., Farukuoye, M., Kacerovsky, M., Schmid, A. I., Gruber, S., Wolzt, M., et al. (2009) · Diabetes · doi:10.2337/db08-1240 · Cited by 75
“Interestingly, nonresponders had higher plasma FFAs, suggesting that increased lipid availability could contribute to impaired fATPase (5), although this might alternatively lead to increased mitochondrial function and biogenesis as demonstrated in rodent models (34,35).”
BackgroundIncreased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Andersen, J. L., Madsbad, S., Worm, D., Helge, J. W., & Dela, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2098-4 · Cited by 73
“However, the issue is controversial and several studies have concluded that mitochondrial respiration is not associated with insulin resistance [7–13], when respiratory capacity is expressed relative to mitochondrial content (i.”
BackgroundPhua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72
“Moreover, in vivo PPARβ/δ overexpression, via electroporation in adult rat muscle, caused an increase in PGC-1α protein levels [82].”
BackgroundDeficiency of the Mitochondrial Electron Transport Chain in Muscle Does Not Cause Insulin Resistance
Han, D.-H., Hancock, C. R., Jung, S. R., Higashida, K., Kim, S. H., & Holloszy, J. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019739 · Cited by 71
“This increase in PGC-1a occurs gradually over about a 4 wk period and is mediated by a post transcriptional effect that appears to result from PPARd activation [22].”
BackgroundSelf-citationApontes, P., Liu, Z., Su, K., Benard, O., Youn, D. Y., Li, X., Li, W., Mirza, R. H., Bastie, C. C., Jelicks, L. A., et al. (2014) · Diabetes · doi:10.2337/db14-0006 · Cited by 69
DiMenna, F. J., & Arad, A. D. (2018) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-018-0110-8 · Cited by 68
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
PPARs and the orchestration of metabolic fuel selection
Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64
The impact of a high-fat diet in mice is dependent on duration and age, and differs between muscles
Messa, G. A. M., Piasecki, M., Hurst, J., Hill, C., Tallis, J., & Degens, H. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.217117 · Cited by 63
“However, several studies in humans and rodents showed an increase in oxidative capacity with HFD (Garcia-Roves et al., 2006; Hancock et al., 2008; Iossa et al., 2002; Li et al., 2016a; Miller et al., 1984; Sadler et al., 2012), rather than a decrease.”
BackgroundMuscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction
Kraegen, E. W., Cooney, G. J., & Turner, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803901105 · Cited by 62
Contribution of the Mitochondria to Locomotor Muscle Dysfunction in Patients with COPD
Taivassalo, T., & Hussain, S. N. A. (2016) · Chest · doi:10.1016/j.chest.2015.11.021 · Cited by 59
Wright, L. E., Brandon, A. E., Hoy, A. J., Forsberg, G.-B., Lelliott, C. J., Reznick, J., Löfgren, L., Oscarsson, J., Strömstedt, M., Cooney, G. J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2068-x · Cited by 57
“For example, we and others have shown that high-fat feeding enhances mitochondrial oxidative capacity in skeletal muscle, even though lipid accumulates and insulin resistance develops in this tissue [4, 5].”
BackgroundHolloway, G. P., Gurd, B. J., Snook, L. A., Lally, J., & Bonen, A. (2010) · Diabetes · doi:10.2337/db09-1519 · Cited by 55
“High-fat feeding has been shown to induce insulin resistance while increasing mitochondrial content (9,11).”
BackgroundDantas, W. S., Roschel, H., Murai, I. H., Gil, S., Davuluri, G., Axelrod, C. L., Ghosh, S., Newman, S. S., Zhang, H., Shinjo, S. K., et al. (2020) · Diabetes · doi:10.2337/db19-1180 · Cited by 54
Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance?
Genders, A. J., Holloway, G. P., & Bishop, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186948 · Cited by 51
Kristensen, J. M., Larsen, S., Helge, J. W., Dela, F., & Wojtaszewski, J. F. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053533 · Cited by 48
Rector, R. S., Uptergrove, G. M., Borengasser, S. J., Mikus, C. R., Morris, E. M., Naples, S. P., Laye, M. J., Laughlin, M. H., Booth, F. W., Ibdah, J. A., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00703.2009 · Cited by 48
Matravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46
“However, given that increased mitochondrial content can parallel the development of IR (15, 19, 53) and that the capacity of ATP production far exceeds reductions in content (16, 21), the relationship between mitochondrial dysfunction and IR remains largely unresolved.”
BackgroundBeck Jørgensen, S., O’Neill, H. M., Hewitt, K., Kemp, B. E., & Steinberg, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1483-8 · Cited by 42
“However, in animal models of obesity and insulin resistance skeletal muscle mitochondrial capacity is increased [14, 15], suggesting that despite increases in mitochondrial capacity, the oxidative rate of muscle is unable to fully compensate for increases in fatty acid delivery and uptake [16, 17].”
Nutritional Considerations for the Vegan Athlete
West, S., Monteyne, A. J., van der Heijden, I., Stephens, F. B., & Wall, B. T. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.012 · Cited by 42
Franko, A., von Kleist-Retzow, J. C., Böse, M., Sanchez-Lasheras, C., Brodesser, S., Krut, O., Kunz, W. S., Wiedermann, D., Hoehn, M., Stöhr, O., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0887-y · Cited by 39
“Moreover, data obtained in rodents suggested that insulin resistance induced by high-fat diet (HFD) rather increased PGC-1α protein levels, activated fatty acid oxidation enzymes, CPT-I, TCA cycle enzymes including CS, and enhanced ADP-stimulated mitochondrial respiration [44, 45].”
BackgroundHandy, R. M., & Holloway, G. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151389 · Cited by 38
“This is in contrast to maintained OXPHOS protein content observed in obese and insulin resistant rodents (Garcia-Roves et al., 2007; Hancock et al., 2008; Miotto et al., 2018) which appears to be caused by mitochondrial ROS-mediated ryanodine receptor calcium leak induced gene transcription (Jain et al.”
BackgroundRoseno, S. L., Davis, P. R., Bollinger, L. M., Powell, J. J. S., Witczak, C. A., & Brault, J. J. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0037-y · Cited by 36
“On the other hand, PGC-1α protein, but not mRNA, levels increase following 4 weeks or more of a high-fat diet [50].”
BackgroundA decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance
Smith, B. K., Holloway, G. P., Reza-Lopez, S., Jeram, S. M., Kang, J. X., & Ma, D. W. L. (2010) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h10-066 · Cited by 35
“2010) and PPAR DNA binding (Hancock et al. 2008) observed in type 2 diabetic and high-fat-fed animals may represent compensatory adaptations to increase mitochondrial content in an attempt to attenuate the progressive loss of insulin sensitivity.”
BackgroundEhrlicher, S. E., Stierwalt, H. D., Newsom, S. A., & Robinson, M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651211 · Cited by 25
“Long-term (3-4 months) diet studies with increased dietary lipid availability increases mitochondrial fatty acid oxidation capacity (6) due to increases in mitochondrial protein abundance (7, 8) and enzyme activity (9).”
BackgroundDasari, S., Newsom, S. A., Ehrlicher, S. E., Stierwalt, H. D., & Robinson, M. M. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00051.2018 · Cited by 21
Brands, M., Hoeks, J., Sauerwein, H. P., Ackermans, M. T., Ouwens, M., Lammers, N. M., van der Plas, M. N., Schrauwen, P., Groen, A. K., & Serlie, M. J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.006 · Cited by 19
Targeting Intramyocellular Lipids to Improve Aging Muscle Function
Russ, D. W., Manickam, R., & Tipparaju, S. M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02622-6 · Cited by 15
“For example, muscle β-oxidation increases in response to a high-fat diet (HFD) [83–86], although excessive lipid content or duration of such diets can exceed this capacity, leading to ectopic lipid accumulation and impaired lipid metabolism [87–91].”
Metadata
- Authors
- Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Holloszy, John O.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-06-03
- Volume
- 105
- Issue
- 22
- Pages
- 7815-7820
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2409421
- OpenAlex
- W2160524748
- Cited by
- 538
- References
- 63
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 16 · 2023: 22 · 2022: 25 · 2021: 25 · 2020: 40 · 2019: 32 · 2018: 32 · 2017: 29 · 2016: 24 · 2015: 28 · 2014: 35 · 2013: 32 · 2012: 35
- FWCI
- 30.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute on Aging (R01AG000425, R37AG000425, Z01AG000425, R56AG000425, AG000425)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK076410, DK-18986, F32DK070425, R01DK018986, DK076410)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, high-fat diet, skeletal muscle mitochondria, PPARδ, PGC-1α, post-transcriptional regulation, free fatty acids, mitochondrial biogenesis, fatty acid metabolism
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Body Weight, Diet, Dietary Fats, Fatty Acids, Nonesterified, Insulin Resistance, Male, Mitochondria, Muscle, Oxidation-Reduction, Transcription Factors, Trans-Activators, Rats, Wistar, Muscle, Skeletal, PPAR delta, Abdominal Fat, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.